NOVOCELL INC has a total of 34 patent applications. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NAKAYAMA TOMOKO, HALO BIO RNAI THERAPEUTICS INC and BBHC CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | China | 5 | |
#3 | United States | 5 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Canada | 3 | |
#6 | Australia | 2 | |
#7 | Brazil | 2 | |
#8 | Republic of Korea | 2 | |
#9 | New Zealand | 2 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Medical technology | |
#6 | Macromolecular chemistry and polymers | |
#7 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Scharp David | 16 |
#2 | Yu Xiaojie | 12 |
#3 | Latta Paul | 10 |
#4 | Yue Chengyun | 10 |
#5 | Hubbell Jeffery | 5 |
#6 | Presnell Sharon C | 5 |
#7 | Schulz Thomas | 4 |
#8 | Hubbell Jeffrey | 4 |
#9 | Robins Allan | 4 |
#10 | Latta Paul P | 4 |
Publication | Filing date | Title |
---|---|---|
WO2005072764A2 | Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells | |
MXPA05003829A | Implantation of encapsulated biological materials for treating diseases. | |
NZ568319A | Implantation of encapsulated biological materials for treating diseases | |
BR0311362A | methods, compositions and growth and differentiation factors for producing insulin producing cells | |
EP0830447A1 | Isolation of cells from pancreas tissue using sonication |